Patients with<unk> s that are also known to be part of neuroendocrine neoplasms must have to deal with two factors related to this tumor. First, controlling the high amounts by using medications that inhibit gastrin levels. The second part is stabilizing the tumor progression.<unk> s have a rate of 60–90% that will become malignant. Patients who do not seek medical treatment such anti-ulcer medication have high rate of recurrence and death secondary to ulcer disease. The prognosis of<unk>  depends on the level of metastases of the tumor. If patients present with hepatic metastases they might have remaining life span of 1 year with a 5-year survival rate of 20–30%. In patients with localized tumor or localized lymph spread the survival rate of 5 years is 90%. Lastly, surgical resection of local tumor could lead to complete cure without recurrence in 20–25% of patients.
Gastrinoma
Glomus tumor
Somatostatinoma
VIPoma
Glucagonoma
Ceruminous adenoma
Insulinoma
Nipple adenoma